Relevance and Efficiency of SecOnd Line Workup for Uveitis
NCT06102408 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2023-10-27
Summary
The first-line etiological workup is currently poorly codified, and some patients undergo sequential investigations. However, the reason which lead the clinician to perform subsequent exams, and the relevance of such exams, remain to be determined. The main objective of the study was to assess the relevance of a second-line workup of patients with uveitis.
Conditions
- Uveitis
Interventions
- OTHER
-
second line investigations for uveitis etiological workup
Biological, radiological or histological investigations performed after a first line etiological workup. Investigations conducted following abnormal resultats of first line exams were not considered as second line exams (e.g. : bronchoscopy performed after abrnomal CT scan).
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-15
- Primary Completion
- 2023-12-15
- Completion
- 2023-12-25
More Related Trials
-
Retrospective Comparison of the Efficacy of Methotrexate and Azathioprine as Background Treatment for Uveitis of Undetermined Origin: Single-centre Retrospective Study From 2005 to 2020
NCT05370690 ·Status: UNKNOWN
-
Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein
NCT03345537 ·Status: COMPLETED
-
Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis
NCT03209219 ·Status: COMPLETED ·Phase: PHASE3
-
Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs
NCT02819206 ·Status: COMPLETED ·Phase: NA
-
Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children
NCT01861561 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
38 Week Extension Study to CAIN457C2303
NCT01093846 ·Status: TERMINATED ·Phase: PHASE3
-
Multi-model Image of Immunosuppressive Agents in TAO
NCT05110040 ·Status: RECRUITING ·Phase: NA
-
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998 ·Status: RECRUITING
-
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
NCT00116090 ·Status: COMPLETED
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
Evaluation Of Non Infectious Presentation of Inborn Errors Of Immunity
NCT05870410 ·Status: UNKNOWN
-
Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis
NCT02863588 ·Status: TERMINATED ·Phase: NA
-
Survey of Patients With Idiopathic Orbital Inflammation Syndrome
NCT01443000 ·Status: COMPLETED
-
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
NCT04664465 ·Status: RECRUITING
-
Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis
NCT06611696 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of Severity in Juvenile and Adult-onset Dermatomyositis
NCT06004817 ·Status: RECRUITING
-
Efficacy Study of Two Treatments in the Remission of Vasculitis
NCT00748644 ·Status: COMPLETED ·Phase: PHASE3
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN
NCT00302549 ·Status: COMPLETED ·Phase: NA
-
Lyon Sarcoid Uveitis Cohort
NCT03863782 ·Status: RECRUITING
-
Eculizumab to Cemdisiran Switch in aHUS
NCT03999840 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of Tofacitinib in Treating ANCA-associated Vasculitis
NCT04973033 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis
NCT00918554 ·Status: TERMINATED ·Phase: PHASE4
-
Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
NCT06894602 ·Status: RECRUITING